Highlights from ASCO 2000 Each year, some 20,000 oncologists and other cancer watchers gather under the auspices of the American Society of Clinical Oncology (ASCO) for the world's largest cancer-related scientific meeting. cancerTrials was there to review the research and report on important clinical trials news.
Listed below are links to articles discussing highlights of the meeting:
Back to Top
Thalidomide Continues Its Comeback Against Multiple Myeloma
(Posted: 05/23/2000, Reviewed: 03/14/2006) - The drug thalidomide appears to be panning out as a legitimate treatment for the resilient blood cancer called multiple myeloma, researchers said at the 2000 American Society of Clinical Oncology annual meeting.
Shorter Course of Radiation Might Be Just as Effective with Early Breast Cancer
(Posted: 05/23/2000, Updated: 10/14/2008) - For some women with early breast cancer, a shorter, more intense course of radiation therapy after surgery may be just as effective as the standard longer course, according to updated results presented at the 2008 annual meeting of the American Society for Therapeutic Radiation and Oncology.
Tamoxifen Found to Be Equally Effective for Black and White Women
(Posted: 05/23/2000) - An analysis reported in May 2000 shows that tamoxifen is as effective for black women as it is for white women in reducing occurence of "contralateral" breast cancer.
Breast Tumor Recurrence: Radiation Plus Tamoxifen May Be Better Than Either Treatment Alone
(Posted: 05/22/2000, Updated: 11/12/2002) - Women with very small breast tumors who received both radiation therapy and the drug tamoxifen after surgery had fewer recurrences of cancer in the same breast than women who received either radiation therapy or tamoxifen but not both, researchers report in the October 15, 2002, issue of the Journal of Clinical Oncology.
A New Treatment for Hot Flashes: Antidepressants
(Posted: 05/22/2000, Updated: 12/16/2000) - Women with breast cancer who suffer hot flashes now have a new option: widely used antidepressant drugs.
Early Breast Cancer Patients Benefit from Shortened Chemotherapy
(Posted: 05/21/2000, Updated: 08/07/2003) - Women with one type of early breast cancer get the same benefit from three months of one chemotherapy as they do from six months of another drug combination.
|